Does Collegium Pharmaceutical (COLL) Have the Potential to Rally 111.39% as Wall Street Analysts Expect?

Impact · against what's priced in

The article provides no material catalysts for COLL, as it merely aggregates existing analyst price targets and earnings trends. Because these consensus expectations are already available to the market, they do not represent new information that would drive a price correction.

COLL+0.00

No priced-in read yet